Fitch affirms Yale New Haven Health’s ‘AA-‘ rating

Fitch Ratings has affirmed the “AA-” rating on Yale New Haven (Conn.) Health’s $842.1 million of bonds.

Advertisement

The rating affirmation is based on a number of factors, including YNNH’s renowned clinical reputation, low debt burden and strong historical operating results.

The outlook is stable.

More articles on healthcare finance:
4 Louisiana safety-net hospitals at risk of closure
Major health systems, payers make progress toward value-based payment goal
6 things to know about medical coding and billing specialists

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.